Abstract
Protein kinase A (PKA) is activated by elevated intracellular cAMP downstream of β-adrenergic signalling. PKA’s subcellular localisation is determined by its affinity for A-kinase anchoring proteins (AKAPs), scaffolds that sequester PKA proximal to its substrates. The regulatory RIα subunits present in type I PKA can form two intermolecular disulphide bonds, each flanking its AKAP-binding domain, in response to oxidants. Rationally this change in the redox state of PKARIα may alter its affinity for AKAP, with potential for consequential regulation of substrate phosphorylation.I made the novel observation that co-treatment of cells with H2O2 and cAMP caused increased global PKA substrate phosphorylation compared to cAMP or H2O2 alone in HEK 293 cells. This suggested RIα serves as a co-incidence detector that integrates the two signals to synergistically enhance PKA substrate phosphorylation. Chronic cAMP treatment increased PKARIα expression in HEK 293 cells and PKARIα was also upregulated in a mouse model of hypertrophy, whilst PKARIIα was downregulated. This may represent a switch to an oxidant sensitive PKA signalling phenotype during chronic β-adrenergic stimulation.
AKAP7 was identified as a potential redox-dependent PKARIα AKAP. Examination of the AKAP7 crystal structure revealed putative redox sensitive cysteines adjacent to its A-kinase binding domain, leading to the hypothesis that the redox state of this AKAP may alter its affinity for PKARIα. I developed and validated the ‘PEG-maleimide switch assay’, a method used to identify proteins that are susceptible to reversible oxidative modification. Using the PEGmaleimide switch assay I found AKAP7 to be insensitive to oxidation. Furthermore, I demonstrated that PKARIIα, but not PKARIα, is a binding partner for AKAP7δ and this interaction was redox modulated.
I described, for the first time, that cAMP can modulate PKARIα disulphide dimer levels. DTTdependent PKARIα reduction was potentiated by cAMP, and cAMP-agarose induced PKARIα reduction. Furthermore, a mutant PKARIα that could not bind cAMP formed disulphide-linked complexes under oxidative conditions. These complexes may be cAMP-regulated intermediates that form during a novel oxidant-dependent mechanism of PKARIα targeting to AKAPs. LC-MS/MS identified the novel AKAP tubulin as part of a disulphide linked complex with PKARIα. Consistent with the hypothesis that oxidants target PKARIα to tubulin, phosphorylation of the microtubule associated protein GEF-H1 was enhanced after cotreatment with cAMP and H2O2 compared to cAMP alone. Thus PKARIα is a co-incidence detector at the interface of cAMP and oxidant signalling that is able to integrate both modalities to fine-tune phosphorylation events.
Date of Award | 2016 |
---|---|
Original language | English |
Awarding Institution |
|
Supervisor | Metin Avkiran (Supervisor) & Philip Eaton (Supervisor) |